Generally, three approaches are used to increase TSP1-mediated inhibition of tumor progression: (1) TSP1-derived peptides, recombinant fragments and mimetics; (2) antibody blockade and gene therapies; (3) upregulation of the potential effects of endogenous TSP1. Here, THBS1 is linked to neoplasm.